u/Different_Band_5462

RGTI, which we see on my 4-Hour Chart below, is reacting to news about the Trump Administration awarding $2 billion in grants to nine quantum-computing companies.

Technically, I can make a compelling argument that all of the price action during the past 3-1/2 months has carved out a rounded bottom formation in the aftermath of a relentless bear phase that pummeled RGTI from its 58.46 ATH on 10/15/25 to a 12.53 low on 3/30/26-- a near-80% devaluation in the share price!

That said, the multi-month base-accumulation period and pattern-- especially after this AM's pop in reaction to the Commerce Department news-- is putting upward pressure on key "upside breakout" resistance lodged between 20.90 and 22.11 that, if (when?) taken out, will trigger an intermediate-term upside reversal signal that projects to 35-38.

Only a sharp downside reversal that retraces the upmove from the 5/19 pivot low at 15.46 to this AM's pre-market high at 20.29 will wreck the currently promising technical outlook.

RGTI is one of the MPTrader Baker's Dozen Most Promising Technical Setups Entering 2026, first posted for members on 12/31/25 at 22.29.

4-Hour RGTI Chart

Technically, CAVA is in a very strong position as long as any forthcoming weakness is contained above or within support between 68 and 73. My 4-Hour Chart argues strongly that CAVA is carving out a 1-1/2 year accumulation period and pattern that has the potential to propel CAVA much higher in the weeks and months ahead, especially if and when CAVA takes out resistance from 94 to 101.

4-Hour CAVA Chart

One of our MPTrader members writes the following this AM:

"What do the charts say about MU? Is there any retreat or exhaustion in the near future? Every dip is violently bought..."

We can tell from my attached 4-Hour and Daily Charts that MU has morphed into a powerful, meteoric parabolic advance.

Here is what my pattern work is telling me about the near-term price path:

-- Yesterday's low at 706.60 off the ATH at 818.67 (5/11/26) represented a low-coordinate for a completed correction ahead of one more thrust to the 860-900 target window that will end the entire advance from 300...

-- Only a bout of weakness that takes out 700 on a closing basis will indicate that the correction from 818.67 to 706.60 was the first downmove of a complex correction that remains in progress, and has a target support window closer to 610-630 prior to my expectation of another advance to 860-900 (probably into and/or in reaction to MU's 6/24/26 Earnings Report...

-- From an intermediate-term perspective, however, the differential between the 200 DMA and where MU is trading 300.76 vs. 805 is historically (and hysterically) wide, and is BIG WARNING SIGN that MU needs a breather sooner or later (probably sooner), which means that MU either peaks and reverses into a scary decline that presses price closer to the 200 DMA, or MU trades in a range (700 to 800 for instance) for two weeks, allowing the 200 DMA to play catch-up.

Right now, my preferred scenario argues for MU to make new ATH's and run closer to 860-900 before reversing sharply into a correction that could see 500 before its exhausted.

Processing img n4keranv5x0h1...

MU 4-Hour Chart

MU Daily Chart

ARKG (ARK Genomic Revolution ETF) is one of our Baker's Dozen Most Promising Technical Setups Entering 2026 (posted to members on Jan 2nd at $29.17).

Although ARKG hasn't moved much so far during 2026, it is positively positioned within a 4-year base-accumulation period and pattern that is exerting upward price pressure toward a challenge of near-term resistance at 31.50/80 and then from 32.00 to 34.80, that, if (when) hurdled, will unleash much higher intermediate-term projections.

Only a bout of weakness that presses and closes beneath the 200 DMA, now at 28.43, will delay the anticipated upside breakout.

I am particularly interested in ARKG because the companies in the ETF prioritize the use of AI for their drug research and analysis of their clinical studies.

Daily ARKG